# Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy

> **NCT01504412** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 450 (actual)

## Conditions studied

- Pain
- Diabetic Peripheral Neuropathy

## Interventions

- **DRUG:** DS-5565
- **DRUG:** DS-5565
- **DRUG:** DS-5565
- **DRUG:** Placebo
- **DRUG:** Pregabalin capsules

## Key facts

- **NCT ID:** NCT01504412
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01504412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01504412, "Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01504412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*